The latest price of crizotinib in 2024

Crizotinib is a small molecule targeted anti-tumor treatment drug that can effectively inhibit the proliferation and survival of tumor cells by targeting tyrosine kinase receptors.

This drug is mainly used to treat patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) and has shown significant efficacy. In addition, crizotinib is also suitable for the treatment of patients with ROS1-positive advanced non-small cell lung cancer. As the first-generation targeted drug for the treatment of lung cancer, crizotinib is widely used around the world. It has obvious efficacy and can reduce the risk of recurrence and metastasis of patients, improve the treatment effect, and thereby prolong the life of patients.

It is worth noting that genetic testing is required before use of crizotinib to confirm whether the patient is suitable for this targeted therapy. At the same time, some side effects may occur during use, so it needs to be used under the guidance of a doctor and regular monitoring of physical conditions.

At present, crizotinib has been launched in China. The domestic specification of crizotinib is 250 mg × 60 tablets. The price after medical insurance reimbursement is around 6,000 yuan. It is recommended to consult the local hospital pharmacy for specific prices. The overseas specification of the original drug launched by Pfizer is 250 mg × 60 tablets, and the price is about 10,000 yuan. It is understood that there are many generic drugs of crizotinib, which come from Laos and Bangladesh. Most of the generic versions are 250 mg × 60 tablets, and the price is about 2,600 yuan; the most cost-effective price of Lucius Pharmaceuticals in Laos is 1,800 yuan per box. If patients want to know more about the generic version of crizotinib, please consult a regular overseas medical consulting company.